Literature DB >> 29974517

Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Tetsuya Kaneko1, Takashi Fujioka1, Yosuke Suzuki1, Toshiaki Nagano2, Yuhki Sato1, Syunji Asakura2, Hiroki Itoh1.   

Abstract

INTRODUCTION: Different measured values for tacrolimus were obtained with different automated immunoassays. We aimed to examine the differences in the blood tacrolimus concentrations measured by the major immunoassay systems commercially available in Japan.
METHODS: Whole-blood samples from 118 patients were assayed by 3 commercial assays: chemiluminescent enzyme immunoassay (CLIA), affinity column-mediated immunoassay (ACMIA), and enzyme-multiplied immunoassay technique (EMIT). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used for reference. KEY
FINDINGS: The correlation coefficient of immunoassay vs LC-MS/MS was excellent for ACMIA (.83) and CLIA (.81) and good for EMIT (.71). The mean error was negative for ACMIA and positive for CLIA and EMIT. The mean absolute error and root-mean-square error were almost the same for ACMIA and CLIA and lower than those for EMIT.
CONCLUSIONS: The ACMIA and CLIA yield considerably better results than the EMIT for monitoring blood tacrolimus concentrations.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  immunoassays; measurement error; tacrolimus; therapeutic drug monitoring

Mesh:

Substances:

Year:  2018        PMID: 29974517      PMCID: PMC6817286          DOI: 10.1002/jcla.22587

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Determination of four immunosuppressive drugs in whole blood using MEPS and LC-MS/MS allowing automated sample work-up and analysis.

Authors:  Rana Said; Anton Pohanka; Mohamed Abdel-Rehim; Olof Beck
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-04-12       Impact factor: 3.205

2.  Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.

Authors:  Kosuke Doki; Masato Homma; Tetsuo Hori; Takashi Tomita; Yuichi Hasegawa; Satoshi Ito; Kiyoshi Fukunaga; Michio Kaneko; Shigeru Chiba; Takayuki Sumida; Nobuhiro Ohkohchi; Yukinao Kohda
Journal:  J Pharm Pharmacol       Date:  2010-09       Impact factor: 3.765

3.  Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.

Authors:  M K Porayko; T A Gonwa; G B Klintmalm; R H Wiesner
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

4.  Phase II FK 506 multicenter concentration control study: one-year follow-up.

Authors:  D A Laskow; F Vincenti; J Neylan; R Mendez; A Matas
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

5.  FK506 measurement: comparison of different analytical methods.

Authors:  V Warty; S Zuckerman; R Venkataramanan; J Lever; J Fung; T Starzl
Journal:  Ther Drug Monit       Date:  1993-06       Impact factor: 3.681

6.  Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Authors:  Tetsuya Kaneko; Takashi Fujioka; Yosuke Suzuki; Toshiaki Nagano; Yuhki Sato; Syunji Asakura; Hiroki Itoh
Journal:  J Clin Lab Anal       Date:  2018-07-05       Impact factor: 2.352

7.  Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.

Authors:  Donatella Moscato; Antonello Nonnato; Rita Adamo; Maria Vancheri; Antonio Caropreso
Journal:  Clin Chim Acta       Date:  2009-10-14       Impact factor: 3.786

8.  Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?

Authors:  M K Ju; H K Chang; H J Kim; K H Huh; H J Ahn; M S Kim; S I Kim; Y S Kim
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

9.  Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.

Authors:  E Ventura; A Bonardet; G P Pageaux; G Mourad; J P Cristol
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

10.  Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.

Authors:  A Bachetoni; P Mariani; M D'Alessandro; V Baiano; C Appodia; D Collepardo; P Berloco
Journal:  Transplant Proc       Date:  2007 Jul-Aug       Impact factor: 1.066

  10 in total
  1 in total

1.  Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Authors:  Tetsuya Kaneko; Takashi Fujioka; Yosuke Suzuki; Toshiaki Nagano; Yuhki Sato; Syunji Asakura; Hiroki Itoh
Journal:  J Clin Lab Anal       Date:  2018-07-05       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.